Where it binds In peer-reviewed studies, the peptide interacts with receptors on blood-vessel cells (VEGFR-2) and shifts the enzymes that produce nitric oxide (eNOS / iNOS)
Published binding studies have characterized the differences quantitatively
After 26 weeks of treatment, women in the intervention group experienced numerous beneficial changes compared to the placebo group, including weight reduction, improved bleeding ratio, decreased androgen levels, and reduced ovarian volume
How Telehealth Peptide Therapy Works Availability varies by state and clinician licensure Online Consultation Process The process starts with a telehealth consultation where a licensed clinician reviews your symptoms, history, and goals
Understanding your genetic profile can help your provider anticipate tolerability patterns and tailor dosing strategy to minimize side effects while maximizing therapeutic benefit